Article Information
History
- July 24, 2020.
Article Versions
- You are currently viewing Version 1 of this article (July 24, 2020 - 21:01).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Drew Weissman1,*,
- Mohamad-Gabriel Alameh1,
- Celia C. LaBranche2,
- Robert J Edwards3,4,
- Laura Sutherland3,
- Sampa Santra5,
- Katayoun Mansouri3,
- Sophie Gobeil3,
- Charlene McDanal2,
- Norbert Pardi1,
- Pamela A. Shaw6,
- Mark G. Lewis7,
- Carsten Boesler8,
- Uğur Şahin8,
- Priyamvada Acharya3,
- Barton F. Haynes3,
- Bette Korber9 and
- David C. Montefiori2,*
- 1Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA
- 2Duke Human Vaccine Institute & Department of Surgery, Durham, North Carolina USA
- 3Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC USA
- 4Duke University, Department of Medicine, Durham NC USA
- 5Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts USA
- 6Department of Biostatistics, Epidemiology and Informatics University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA
- 7Bioqual Inc., Rockville, MD USA
- 8BioNTech, Mainz, Germany
- 9T6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA
- ↵*Address correspondence to Drew Weissman, drew{at}pennmedicine.upenn.edu or David Montefiori, david.montefiori{at}duke.edu.
Posted July 24, 2020.
